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ABSTRACT
Objectives: 1H NMR-metabolomic approach was used to investigate QTc interval correlation with
plasma metabolic profiles in shiftworkers.
Methods: Socio-demographic data, electrocardiographic QTc interval and plasma metabolic profiles
from 32 male shiftworkers, were correlated by multivariate regression analysis.
Results: We found a positive correlation between QTc interval values, body mass index, glycemia and
lactate level and a negative correlation between QTc interval and both pyroglutamate and 3-hydroxybu-
tyrate plasma level.
Conclusions: Our analysis provides evidence of the association between clinical, metabolic profiles and
QTc interval values. This could be used to identify markers of early effects and/or susceptibility in
shiftworkers.
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Introduction
In the electrocardiographic record, the QT interval is the inter-
val between the onset of the QRS complex that is the earliest
indication of ventricular depolarization, and the end of the T
wave, that is the latest indication of ventricular repolarization
(Rautaharju et al., 2009). Prolongation of the heart rate
adjusted QT interval (LQTc) can predict a polymorphic ven-
tricular tachycardia known as ‘‘Torsades de pointes’’ that con-
sists in the oscillation of the QRS complex around the
isoelectric line, and is associated with syncopal episodes, and
possible evolution to ventricular fibrillation and sudden death
(Giorgi et al., 2010).
LQTc can be either congenital or acquired. Congenital
forms are inherited as Mendelian characters, and are associ-
ated with an elevated risk of arrhythmogenic sudden death
(Kannankeril et al., 2010). Drugs that can interfere with ionic
flow through the Kþ channels, such as antipsychotics, are by
far the most common cause of acquired LQTc, which is in
turn associated with a significantly increased risk of malignant
ventricular arrhythmia (Isbister & Page, 2012). Some authors
speculated that the QTc interval can be influenced by shift-
work, and particularly by working unpredictable and nonstan-
dard working hours, and proposed monitoring QTc as an
early marker of cardiovascular disorders (CVD) among shift-
workers (Meloni et al., 2013; Murata et al., 1999). However,
LQTc can be also considered as a marker of susceptibility in
workers exposed to different working schedules. Considering
the global burden of CVD and its impact in morbidity, mortality
and health costs (WHO, 2011), and the relevant proportion of
shiftworkers in industrialized countries (16–20%), introducing
workplace screening of early adverse cardiovascular effects and
cardiovascular hypersusceptibility can be of special interest in
modern occupational health, particularly if coupled with the
use of metabolomics and other OMICS technologies (Rasmiena
et al., 2013; Vlaanderen et al., 2010). In particular, metabolomics,
as ‘‘a global holistic overview of the personal metabolic status’’,
can be useful to identify individuals at risk due to the inter-
action between genetic, environmental, occupational and life-
style factors (Holmes et al., 2008; Lindon & Nicholson, 2008), by
means of the quali-quantitative analysis of a large number of
metabolites that are stable compounds with a unique structure
and a biological role (Dunn et al., 2011; Wishart et al., 2009).
To the best of our knowledge, only one report has been
published which applied a metabolomic approach to assess
metabolic patterns associated with an increase in risk of
developing QTc prolongation in Guinea pigs exposed to
increasing doses of sparfloxacin, a compound belonging to the
third-generation family of Fluoroquinolones, known to induce
QTc prolongation (Park et al., 2013). No metabolomics studies
have been published so far to identify LQTc related metabolic
factors in humans.
The aim of the present study was to assess whether QTc
interval values correlate with the metabolic profile in a work-
ing population with unpredictable and nonstandard working
hours, using a 1H nuclear magnetic resonance (NMR)-metabo-
lomics approach.
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Methods
Study population
During the 2013 annual workplace health surveillance pro-
gram, we examined 32 male workers of a cargo-handling
trans-shipping company. All subjects agreed to participate in
the study and gave written informed consent prior to partici-
pation. For each study subject, we recorded demographic
and lifestyle variables, such as alcohol intake and smoking
habits, health history and clinical variables, including body
mass index (BMI), systolic and diastolic pressure, glycemia,
heart rate and the electrocardiographic QTc interval.
Electrocardiograms (ECG) were performed between 07:00
and 10:00 a.m. using a P80 Power-ESAOTE machine (Florence,
Italy) the first day upon return to work or after no more than
one day shift. Study subjects had to rest in the supine pos-
ition for 10min. As QT interval is influenced by heart rate, for
each study subject, RR intervals on the ECG were measured
in real time for heart rate correction. The QTc interval was
automatically calculated by the equipment from the RR and
QT intervals on the ECG according to the Bazett’s square root
formula (QTc¼QT/RR), in V1–V6, from the onset of QRS
complex to the end of the T wave at the point in which it
returns to the isoelectric line, and visually validated according
to the recommendations from the American Heart
Association, Electrocardiography and Arrhythmias Committee,
Council on Clinical Cardiology, the American College of
Cardiology Foundation and the Heart Rhythm Society
(Rautaharju et al., 2009). We considered a QTc length less
than 430ms as normal, between 430 and 450ms as border-
line, and greater than 450ms as prolonged, according to pub-
lished reference values (Yap & Camm, 2003).
Metabolomics approach
Our metabolomics approach consists of two sequential phases:
(1) the use of high resolution 1H NMR spectroscopy to profile
the full set of metabolites in plasma samples and (2) the inter-
pretation of spectral data, together with the clinical data, by
principal component analysis (PCA) and partial least squares
(PLS) regression (Barker & Rayens, 2003). Results were visualized
in the score 2D-plot, where samples are projected in the space
spanned by the principal components (PCs) that summarized
all the variables giving higher importance (weight) to those
exhibiting higher covariance, and the corresponding loading
(weight) plot where the variables are reported. Loading plot
can be depicted as scatter 2D-plot or as column plot that
shows loading correlation values along one component.
Blood sample collection
Blood samples were collected in heparin vials before execut-
ing the ECG, and immediately centrifuged at 4000 rpm for
15minutes; the supernatant was then divided into 800ll
plasma aliquots and stored at 80 C.
Plasma chloroform/methanol/water extraction
All plasma samples were thawed and centrifuged at
12,000 rpm for 10min; the supernatants were processed using
chloroform/methanol/water extraction. Plasma aliquots were
added with 2.4ml of chloroform/methanol (1:1 vol/vol) and
350 ll of H2O, vortexed for 30 s, and centrifuged at 4500 rpm
for 30min. After centrifugation, the hydrophilic fractions were
collected. Approximately 1ml of the hydrophilic fraction was
dried overnight using a Speed Vacuum Concentrator
(Eppendorf) and stored at 80 C until NMR analysis.
1H NMR spectroscopy
1H NMR experiments were performed using a Varian UNITY
INOVA 500 spectrometer operating at 499.839MHz for proton,
equipped with a 5-mm double resonance probe (Agilent
Technologies, Santa Clara, CA). At the moment of analysis,
dried hydrophilic plasma extracts were re-dissolved with
650 ll of D2O (99.8%, Cambridge Isotope Laboratories Inc.,
Andover, MA) containing the internal standard sodium 3-(tri-
methylsilyl)propionate-2,2,3,3-d4 (TSP. 98 atom % D, Sigma-
Aldrich, Milan, Italy) at a 0.3-mM final concentration, and
transferred into a 5-mm NMR tubes. 1H NMR spectra were
acquired at 300 K with a spectral width of 6000Hz, a 90
pulse, an acquisition time of 2 s, a relaxation delay of 2 s and
256 scans. The residual water signal was suppressed by apply-
ing a presaturation technique with low power radiofrequency
irradiation for 2 s.
1H NMR data processing and multivariate statistical
analysis
1H NMR spectra were imported in the MestReNova software
(Version 7.1.2. Mestrelab Research S.L., Santiago de
Compostela, Spain), preprocessed with line broadening of
1 Hz, zero-filled to 64 K, and Fourier transformed. All spectra
were phased and baseline corrected. Chemical shifts were
referred to the TSP single resonance at 0.00 ppm. Assignment
of NMR resonances to metabolites was based mainly on lit-
erature data (Wishart et al., 2009), and on the database of
Chenomx NMR suite 7.1 (Chenomx Inc., Edmonton, AL,
Canada). To make information contained in the 1H NMR spec-
tra suitable to perform statistical analysis, they were reduced
into consecutive integrated spectral regions (bins) of equal
width (0.04 ppm) corresponding to the region 0.50–8.62 ppm.
The spectral region between 4.26 and 6.22 ppm was excluded
from the analysis, because it presents artifacts from water sig-
nal suppression. The integrated area within each bin was nor-
malized to a constant sum of 100 for each spectrum, in order
to minimize the effects of variable concentration among dif-
ferent samples. In this manner, 150 variables that represent
the spectral profile for each sample were obtained.
Furthermore, data from clinical reports (age, BMI, systolic and
diastolic blood pressure, glycemia) were added as continuous
variables to the NMR data. To distill the latent information
contained in the spectral and clinical data related to QTc
interval, we performed multivariate statistical analysis with
the aid of SIMCA-Pþprogram (Version 13.0. Umetrics, Malm€o,
Sweden). Mean-centering was applied column-wise, spectral
data were Pareto scaled, while clinical data were scaled to
unit variance. PCA and PLS regression modeling and its
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orthogonal (OPLS) implementation (Eriksson et al., 2013) were
performed. As QTc value was the unique outcome, the PLS-1
algorithm was used. Model quality was evaluated on the basis
of the R2 (goodness of fit) and Q2 (goodness of prediction
determined through the default leave-1/7th-out cross valid-
ation) parameters.
Ethics statement
The study protocol was notified to the competent
Institutional Review Board, the Ethics Committee of the
Cagliari University Hospital. Due to the observational nature
of the study, in absence of any additional invasive procedure
beyond the routine mandatory health screening protocol, and
in absence of any involvement of therapeutic medication,
based on the guidelines of the Italian Drug Agency (2008) no
formal approval was required. Nonetheless, all participating
subjects gave written informed consent prior to participation.
Results
Selected characteristics of our study population are reported
in Table 1. Six study subjects (14%) had a condition
potentially associated with a prolonged QTc interval (four
hypertension, one ischemia, one diabetes); none reported
undergoing medication with drugs potentially affecting the
QTc interval. QTc intervals in the study population were
within the normal range in 24 subjects, borderline in 6, and
prolonged in 2.
Plasma hydrophilic extracts were analyzed by 1H NMR
spectroscopy. Figure 1 shows the aliphatic region of a repre-
sentative 1H NMR spectrum including assignment of the
major metabolites identified.
To investigate sample characteristics a PCA of spectral and
clinical data was performed, the first two PCs accounted for
47% of the variance. As shown in Figure 2(A), all samples lie
within the confidence bounds indicating the absence of out-
liers. We did not observe clusters or trends associated with
QTc. The descriptive quality of the PCA model was assessed
by the good relationships between metabolites and clinical
data that can be evinced by the visual analysis of the loading
plot in Figure 2(B). Along PC1 (x-axis), glycemia and glucose
are close each other and opposite to metabolites involved in
energetic supplies such as BCAA (branched chain amino
acids); in this latter multivariate region of the plot, 3-hydroxy-
butyrate, lysine and pyroglutamate are also present. BMI, age,
systolic and diastolic blood pressure form a cluster with lac-
tate along the second component (y-axis).
In the attempt to correlate QTc interval values with
1H NMR spectral profiles, with the aid of clinical data, we per-
formed an OPLS with QTc values as the outcome. Figure 3(A)
shows the OPLS score plot, where a pattern of QTc values
can be observed along the predictive component (x-axis).
Results indicate that BMI, lactate, age, glycemia, glucose and
systolic blood pressure are positively correlated to QTc values,
while lysine, pyroglutamate, 3-hydroxybutyrate and acetate
are inversely correlated (Figure 3B). OPLS metabolites and
clinical data exhibiting the strongest (positive or negative)
Table 1. Clinical data of the study population.
Mean SDa Min Max
Age (years) 44 6.8 32 60
Height (cm) 173 5.4 162 183
Weight (kg) 76 9.5 53 98
BMI (kg/m2) 26 3.1 18 31
QTc (ms) 414 22.5 369 453
Systolic blood pressure (mmHg) 122 9.1 110 150
Diastolic blood pressure (mmHg) 80 6.2 70 90
Heart rate (f/m) 66 9.6 52 90
Glycemia (mg/dl) 91 11.9 73 130
aStandard deviation.
Figure 1. Aliphatic region of a representative 1H NMR spectrum of a plasma hydrophilic extract in D2O. Major assignments are reported. Branched chain aminoacids
(BCAA: isoleucine, leucine and valine), 3-hydroxybutyrate (3-HB), lactate (Lac), alanine (Ala), lysine (Lys), acetate (Ace), N-acetyl groups (N-Ace), glutamine (Gln), pyro-
glutamate (PGlu), citrate (Cit), creatine/creatinine (Crt/Crn), betaine (Bet), scyllo-inositol (SI), glucose (Gluc) and glycerol (Glyc).
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correlation with QTc interval values are reported in Table 2.
The combined use of spectral data and clinical information
allowed a good model quality (R2Y¼ 0.90, Q2¼0.69) to be
achieved.
Discussion
In this study we found, using a 1H NMR-based metabolomic
approach to characterize biochemical patterns related to QTc
interval in shiftworkers, a positive correlation between QTc
interval values and several clinical and demographical data
(such as BMI, glycemia, systolic blood pressure and age)
together with some metabolic ones (such as lactate and glu-
cose metabolites). Our findings are consistent with previous
reports in underlining a putative association of QTc prolonga-
tion with age, obesity, metabolic syndrome, diabetes and also
with hyperglycemia and insulin resistance (Faramawi et al.,
2008; Li et al., 2009; Queen et al., 2012). A correlation
between blood glucose concentration and QTc interval has
also been confirmed in non diabetic patients independently
on the aforementioned cardiovascular risk factors, such as
dyslipidemia and obesity (Grandinetti et al., 2005; Kubiak
et al., 2010). Long QTc in subjects affected by hypertriglyceri-
demia, hyperglycemia and obesity, might be in fact related to
an increase in oxygen consumption and in heart rate in these
subjects (el-Gamal et al., 1995). An association between sys-
tolic blood pressure and QTc interval has also been reported,
suggesting a possible role of hypertension in LQTc mediated
by ventricular arrhythmias (Barison et al., 2011). In the present
study, systolic blood pressure values, but not diastolic ones,
were positively associated with LQTc.
Our results also indicate that QTc interval values are
inversely correlated in our shiftworkers cohort to pyrogluta-
mate, 3-hydroxybutyrate and acetate.
Pyroglutamic acid can be found in several food items
such as cheese, fruit, meat and vegetables, having been
suggested by animal and in vitro studies a protective role
against neuropathy (Silva et al., 2001). Among its several func-
tions, some authors recently suggested a possible anti-dia-
betic action of pyroglutamic acid, in an animal setting, related
to its ability to improve glucose tolerance either by down-
regulating glycolysis and gluconeogenesis, or by suppressing
the increase in plasma glucose levels (Yoshinari & Igarashi,
2011).
3-Hydroxybutyric acid is a ketone body resulting from the
conversion of cystathionine to cysteine in the methionine-to-
glutathione pathway. Like all the other ketone bodies (acetoa-
cetate and acetone), its levels in blood and urine increase in
ketosis and may be used in diabetic patients as a marker of
ketoacidosis.
Figure 2. PCA model of subjects with different QTc interval values. (A) Score plot of samples (boxes: subjects with prolonged QTc interval values, circles: borderline,
and triangles: normal). (B) Loading plot of variables (spectral and clinical data) with enlarged region. Abbreviations: Branched chain aminoacids (BCAA: isoleucine, leu-
cine, and valine), 3-hydroxybutyrate (3-HB), lactate (Lac), alanine (Ala), lysine (Lys), acetate (Ace), N-acetyl groups (N-Ace), glutamine (Gln), pyroglutamate (PGlu), cit-
rate (Cit), creatine/creatinine (Crt/Crn), betaine (Bet), scyllo-inositol (SI), glucose (Gluc), glycerol (Glyc).
4 M. CAMPAGNA ET AL.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ita
 D
eg
li S
tud
i d
i C
ag
lia
ri]
 at
 03
:22
 05
 M
ay
 20
16
 
Acetate is implicated in fatty acid synthesis and in lipogen-
esis in the adipose tissue. It has been recently proposed as a
mediator in reducing appetite via a central homeostatic mech-
anism (Anastasovska et al., 2012; Frost et al., 2013). Glucose and
acetate plasmatic concentrations seem to be associated, even if
a causative relationship has not been so far proposed. Their
biological link may be an enzymatic one and it may rely on the
functional insulin mediated-regulation of acetylcoenzyme
A synthetase (ACAS; involved in the conversion of acetate to
acetyl-CoA), existing some evidence of a conversion between
acetate and glucose via acetyl-CoA (Akanji et al., 1989).
The overall metabolic pattern here described seems to be
strictly interrelated with glycemic homeostasis, suggesting a
causative relationship between elevation of blood glucose
level, QTc prolongation and shiftwork.
The described correlation among QTc prolongation and
higher values of systolic blood pressure, BMI, blood glucose
(expressed either as glycemia and NMR signals, independently
from absence/presence of insulin resistance), together with
the inverse relation to pyroglutamate, 3-hydroxybutyrate and
acetate, underlines a common metabolic way that could
impair autonomic activity influencing QTc interval, even with-
out neuropathy (Fiorentini et al., 2010). Moreover, several
studies, based on intensive glycemic control, suggest a pos-
sible causative correlation between a hypo/hyper-glycemic
status and an excess of cardiovascular morbidity and mortal-
ity in patients with type 1 and 2 diabetes via arrhythmias and
modification of cardiac autonomic activity (The ACCORD
Study Group, 2011).
There is a growing need to understand the molecular basis
of CVD in order to identify effective screening tools to moni-
tor cardiovascular risk factors at the general population and
occupational health level. CVD is, in fact, the major contribu-
tor to global mortality and morbidity in industrialized coun-
tries, and the related economic and healthcare costs
Figure 3. OPLS model with QTc interval values as response. (A) Score plot of samples (boxes: subjects with prolonged QTc interval values, circles: borderline and trian-
gles: normal). (B) Loading column plot of variables (spectral and clinical data) along the predictive component t[1].
Table 2. OPLS metabolites and clinical data correlated
to QTc interval values.
Directly correlated Inversely correlated
BMI Lysine
Lactate Pyroglutamate
Age 3-Hydroxybutyrate
Glycemia Acetate
Glycerol Glutamine
SBP
Glucose
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represent a major public health policy concern (WHO, 2011).
It is well known that cardiovascular risk is strongly related to
obesity, elevated blood pressure, hyperglycemia and dyslipi-
demia. Early asymptomatic factors, such as LQTc, are less
known. QTc is, in fact, considered as a prognostic factor of
arrhythmia, but the physiopathological mechanisms remain
still not fully understood (Park et al., 2013). Shiftwork is
reported as a risk factor for the development of CVD (Frost
et al., 2009; Murata et al., 1999, 2005). A multifaceted and
multivariate approach, linking clinical variables with metabo-
lomic patterns, can represent a useful tool to stratify cardio-
vascular risk in shiftworkers and identify hypersusceptible
subjects together with tailored individual preventive meas-
ures to contain the risk.
In researches focused on the understanding of the etiopa-
thological mechanisms of QTc prolongation, metabolomics
can in fact allow to acquire qualitative and quantitative infor-
mation concerning the metabolites that occur under normal
circumstances and to detect perturbations in the metabolites
as result of environmental exposure (Vlaanderen et al., 2010).
Global metabolomic profiling, together with a multivariate
statistical approach, may play a key role in discovering meta-
bolic phenotypes that can predict individual QTc prolongation
as a consequence of exposure of exogenous risk factors (such
as shiftwork, drugs, diabetes, metabolic syndrome and so on).
It can make it possible to identify biomarkers of complex and
low dose exposure or early effects in human population and
detect biochemical changes of disease or exposure prior to
more overt signs of adverse health effects (Bonvallot et al.,
2013; Dudka et al., 2014; Wang et al., 2012).
As already observed in animal models (Park et al., 2013),
this approach might also be useful to identify subjects at risk
of developing LQTc also among those under medication, par-
ticularly with antipsychotic drugs. Considering the burden of
subjects undergoing antipsychotic treatment, public health
implications could be relevant. Also, the metabolic genotypes
and phenotypes associated to LQTc may be helpful to under-
standing its origin and to suggest new researches to identify
patterns of susceptibility in shiftworkers.
Some limitations need to be considered interpreting our
findings. The sample size of our study population and the
observed prevalence of LQTc are too small to allow any gen-
eral inference to be drawn. Moreover, we did not have a ref-
erence group to test differences in metabolic profiles
compared to shiftworkers, and we did not conduct a longitu-
dinal analysis to study modifications of QTc in relation to
metabolic and clinical phenotypes. In spite of such limitations,
our explorative analysis provides initial evidence for the asso-
ciation of clinical and metabolic profiles with the QTc interval
which could be useful in further studies to identify markers of
early effects and/or susceptibility, especially in shiftworkers.
We will address further efforts in this direction. Our find-
ings support the application of a metabolomics approach to
the study of exogenous risk factors of QTc prolongation in
humans. This is the first metabolomic study, at the best of our
knowledge, conducted in humans in relation to QTc
interval and it can represent a first step in future research field
in both occupational health as well as in cardiology and
pharmacology.
Disclosure statement
None of the authors declare any competing interests in the matters
related to this paper.
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